WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles:
Related suggestion:
West accused of dragging Russia into arms raceEmpower youths to bridge rural digital divideAll suggestions given to State Council in 2023 addressed: officialEmpower youths to bridge rural digital divideProcuratorates advance public interest litigationGBA integration a focus of attention at CPPCCXinjiang to open up further to world despite West's smearingCPPCC hosts science lecture on general AISenior adviser upbeat about HK's futureXi emphasizes need to develop new quality productive forces
0.1288s , 6502.265625 kb
Copyright © 2024 Powered by Vertex Pharma scientist talks about the long road to developing non ,International Investigation news portal